MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202641112046 A) filed by Dr. G. Raveendra Babu; S. Rajasekhar; Dr. M. Bargavi; Dr. P. S. S. Prasan Kumar; Dr. P. Mohan Vikas; and Dr. N. Sai Krishna on September 18, 2026, for "the Robotic Paradigm Of Analyzing Ai'S Transformative Power In Modern Pharmaceutics And Industrial Systems.
Inventors include Dr. G. Raveendra Babu; S. Rajasekhar; Dr. M. Bargavi; Dr. P. S. S. Prasan Kumar; Dr. P. Mohan Vikas; and Dr. N. Sai Krishna.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: At the crossroads of the future pharmacy, medicine, and industry lie robotic automation and artificial intelligence. Thus, this chapter takes inspiration from Industry 4.0 developments to discuss the way robotic systems, automated micro bioreactors, continuous manufacturing offer solutions to contemporary problems while enhancing productivity and safety. The dosage, mixing, and packaging are carried out with the utmost precision by applying real-time quality control checks, reducing risks of contamination, and human error. An intelligent factory, built on an AI-controlled automation environment, cloud computing, and big data analytics, would promote production flexibility and regulatory compliance. Specific emphasis on supply chain optimization, sterile processing, and human robot collaboration key areas in sustainable innovation is made. Insights will bring interdisciplinary integration impacts that go further than industrial enhancement to setting a framework for safe human—robot cooperation. Prospective applications in drug discovery, personalized medicine, and bioprocessing that keep pace with changing global demands for healthcare.
Disclaimer: Curated by HT Syndication.
